imidocarb-dipropionate and Hematologic-Diseases

imidocarb-dipropionate has been researched along with Hematologic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for imidocarb-dipropionate and Hematologic-Diseases

ArticleYear
Administration of diminazene aceturate or imidocarb dipropionate for treatment of cytauxzoonosis in cats.
    Journal of the American Veterinary Medical Association, 1999, Aug-15, Volume: 215, Issue:4

    Bobcats (Lynx rufus) are the reservoir hosts for Cytauxzoon felis, the causative agent of cytauxzoonosis. Cytauxzoonosis is a highly fatal tickborne blood protozoal disease of domestic and exotic cats. Treatment of clinically affected cats has generally been unrewarding. In our report, 6 of 7 cats had signs of illness and laboratory findings indicative of cytauxzoonosis and were successfully treated with 2 i.m. injections of diminazene aceturate or imidocarb dipropionate (2 mg/kg [0.9 mg/lb] of body weight, each). One cat died after the first injection of diminazene. Additional treatment with isotonic fluids i.v. and heparin s.c. were used as supportive care for dehydration and disseminated intravascular coagulation that were detected by laboratory testing between diminazene or imidocarb treatments. Atropine was effective in recovery and preventing adverse reactions associated with imidocarb treatment of 1 cat.

    Topics: Animals; Antiprotozoal Agents; Blood; Blood Transfusion; Body Temperature; Cat Diseases; Cats; Diminazene; Erythrocyte Count; Hematocrit; Hematologic Diseases; Heparin; Imidocarb; Injections, Intramuscular; Isotonic Solutions; Leukocyte Count; Male; Piroplasmida; Protozoan Infections; Protozoan Infections, Animal; Urinalysis

1999